Imunon (IMNN) News Today $0.61 -0.04 (-6.91%) Closing price 07/11/2025 04:00 PM EasternExtended Trading$0.60 -0.01 (-0.84%) As of 07/11/2025 07:56 PM Eastern Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more. Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock IMNN Latest News All Sources Trusted Sources MarketBeat Benzinga Bloomberg GlobeNewswire GuruFocus MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha TalkMarkets The Street TipRanks The Wall Street Journal Wall Street Zen Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent July 2025 June 2025 May 2025 April 2025 March 2025 February 2025 January 2025 December 2024 November 2024 October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 Time Period Imunon, Inc. (IMNN) - Yahoo FinanceJuly 5, 2025 | finance.yahoo.comWall Street Zen Upgrades Imunon (NASDAQ:IMNN) to HoldJuly 5, 2025 | americanbankingnews.comImunon, Inc.’s Promising Study on IMNN-001 for Ovarian Cancer: A Market PerspectiveJuly 3, 2025 | tipranks.comImunon, Inc. Advances Phase II Study on IMNN-001 for Ovarian CancerJuly 3, 2025 | tipranks.comIMUNON Presents Positive Phase 2 Results For IMNN-001 In Advanced Ovarian Cancer At ESMO 2025June 20, 2025 | nasdaq.comIMNN: Translational Data from OVATION 2 Presented…June 20, 2025 | finance.yahoo.comIMUNON Reports Six-Month Durability and Manufacturing Benefits of PlaCCine® DNA Vaccine Technology Over mRNA Vaccines, Seeks Strategic PartnershipJune 18, 2025 | nasdaq.comIMUNON Presents Positive Phase 2 Translational Data of IMNN-001 in Advanced Ovarian Cancer at ESMO Gynaecological Cancers Congress 2025June 18, 2025 | globenewswire.comIMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™June 17, 2025 | globenewswire.comImunon Appoints Kimberly Graper as Interim CFOJune 13, 2025 | tipranks.comIMUNON to Present at the Zacks SCR Life Sciences Virtual Investor Forum on June 12thJune 6, 2025 | finance.yahoo.comASCO25: Imunon shares positive results from trial of IMNN-001 for ovarian cancerJune 4, 2025 | finance.yahoo.comIMUNON Announces Data Presented at ASCO Reinforces Unprecedented Overall Survival in Ovarian Cancer Phase 2 StudyJune 3, 2025 | globenewswire.comIMNN: Momentum Continues with Presentations at ASCO and ESMO Gynaecological Cancers…June 2, 2025 | finance.yahoo.comIMUNON CEO RECAPS A YEAR OF CLINICAL ACHIEVEMENT AND SOLID FUNDAMENTALSJune 2, 2025 | globenewswire.comImunon Inc. Faces Nasdaq Delisting Over Compliance IssuesJune 1, 2025 | uk.investing.comWhy Imunon, Inc. (IMNN) Surged Last WeekMay 31, 2025 | msn.comIMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025May 29, 2025 | seekingalpha.comImunon, Inc. (IMNN) Raises $3.25M in Private Placement, Eyes $6.5M MoreMay 28, 2025 | insidermonkey.comIMUNON Closes Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq RulesMay 28, 2025 | finance.yahoo.comImunon Jumps 96% On Phase 2 Immune Biomarker Data Reveal Ahead of ESMO Congress; Retail Expects ‘Major’ Partnership News SoonMay 27, 2025 | msn.comImunon announces up to $9.75M private placement priced at-the-marketMay 27, 2025 | finance.yahoo.comIMUNON Invited to Present Translational Data in Supporting Remarkable Phase 2 Ovarian Cancer Survival Results at ESMO Gynaecological Cancers Congress 2025May 27, 2025 | globenewswire.comIMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced ...May 25, 2025 | seekingalpha.comImunon shares soar on promising ovarian cancer trial resultsMay 23, 2025 | investing.comBiotech Stock Surges To Close The Week After Major AnnouncementMay 23, 2025 | msn.comIMUNON Announces Up To $9.75 Million Private Placement Priced At-The-Market Under Nasdaq RulesMay 23, 2025 | globenewswire.comImunon, Inc.: IMUNON Announces Withdrawal of Form S-1 Registration StatementMay 23, 2025 | finanznachrichten.deIMUNON Announces 2025 ASCO Annual Meeting Oral Presentation Highlighting Unprecedented Survival Data from Phase 2 Trial of IMNN-001 in Treatment of Newly Diagnosed Advanced Ovarian CancerMay 23, 2025 | globenewswire.comRetail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’May 23, 2025 | msn.comRetail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’May 23, 2025 | msn.comIMUNON Announces Withdrawal of Form S-1 Registration StatementMay 22, 2025 | globenewswire.comImunon faces Nasdaq delisting over equity shortfallMay 21, 2025 | investing.comD. Boral Capital Downgrades Imunon (IMNN)May 20, 2025 | msn.comIMNN: First Site Activated for Phase 3 OVATION 3 Trial…May 15, 2025 | finance.yahoo.comIMUNON Announces Six-Month Data Showing Durability of Protection for Next-Generation DNA Vaccine Platform in Phase 1 Clinical Trial in COVID-19May 15, 2025 | globenewswire.comIMUNON, Inc. Initiates First Site for Phase 3 OVATION 3 Study of IMNN-001 in Advanced Ovarian Cancer, Announces ASCO PresentationMay 13, 2025 | nasdaq.comImunon Inc (IMNN) Q1 2025 Earnings Call Highlights: Strategic Advances Amid Financial ChallengesMay 13, 2025 | finance.yahoo.comImunon, Inc.: IMUNON Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 13, 2025 | finanznachrichten.deImunon outlines 40% trial cost reduction and early readout potential as OVATION 3 Phase III launchesMay 13, 2025 | msn.comImunon, Inc. Earnings Call: Clinical Progress Amid Financial ChallengesMay 12, 2025 | tipranks.comImunon, Inc. (IMNN) Q1 2025 Earnings Call TranscriptMay 12, 2025 | seekingalpha.comIMUNON Reports First Quarter 2025 Financial Results and Provides Business UpdateMay 12, 2025 | globenewswire.comImunon, Inc.: IMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian CancerMay 10, 2025 | finanznachrichten.de2IMNN : Imunon's Earnings: A PreviewMay 9, 2025 | benzinga.comIMUNON Announces First Site Initiated for Pivotal Phase 3 OVATION 3 Study of IMNN-001 in Newly Diagnosed Advanced Ovarian CancerMay 8, 2025 | globenewswire.comIMUNON to Hold First Quarter 2025 Financial Results and Business Update Conference Call on Monday, May 12, 2025May 5, 2025 | globenewswire.comImunon announces IMNN-001 abstract accepted for oral presentation at 2025 ASCOApril 22, 2025 | markets.businessinsider.comIMUNON Announces IMNN-001 Abstract Accepted for Oral Presentation at 2025 ASCO Annual MeetingApril 21, 2025 | globenewswire.comImunon Stock Short Interest Report | NASDAQ:IMNN | BenzingaApril 20, 2025 | benzinga.com Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address IMNN Media Mentions By Week IMNN Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. IMNN News Sentiment▼0.630.99▲Average Medical News Sentiment IMNN News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. IMNN Articles This Week▼12▲IMNN Articles Average Week Get Imunon News Delivered to You Automatically Sign up to receive the latest news and ratings for IMNN and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies AVTX News Today IPA News Today RENB News Today BLUE News Today ADVM News Today VRCA News Today DTIL News Today AADI News Today ATRA News Today RNXT News Today Headlines Tools Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:IMNN) was last updated on 7/13/2025 by MarketBeat.com Staff From Our PartnersINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredPresidential Bombshell: $150T Resource to Be Released as soon as this Summer?Something extraordinary is happening in Washington. For the first time in over a century, a sitting Preside...Paradigm Press | Sponsored[No Brainer Gold Play]: “Show me a better investment.”A Historic Gold Announcement Is About to Rock Wall Street? For months, sharp-eyed analysts have watched the...Golden Portfolio | SponsoredTrump’s treachery Trump’s Final Reset Inside the shocking plot to re-engineer America’s financial system…and why you need to ...Porter & Company | SponsoredGoogle did what!?!?A new technology has sparked a modern-day gold rush in Silicon Valley. OpenAI’s Sam Altman invested $375M. Bil...Stansberry Research | SponsoredBanks aren’t ready for this altcoin—are you?Our expert analysts have identified a $100 billion gap in the crypto market. Only one project is perfectly ...Crypto 101 Media | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Imunon, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Imunon With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
